首页> 外国专利> APPLICATION OF NEURAMINIDASE AND INHIBITORS THEREOF IN MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION

APPLICATION OF NEURAMINIDASE AND INHIBITORS THEREOF IN MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION

机译:神经氨酸酶及其抑制剂在心肌缺血和心肌梗死中的应用

摘要

The present invention discloses an application of neuraminidase and inhibitors thereof in myocardial ischemia and myocardial infarction, provides a correlation between neuraminidase and myocardial ischemic damage to prove the myocardial ischemic damage can be alleviated by inhibiting the activity of neuraminidase, and to prove the neuraminidase can be used as a target for screening drugs for preventing, alleviating and/or treating myocardial ischemic damage. The present invention also demonstrates the alleviating effect of neuraminidase inhibitors on myocardial ischemic damage. Neuraminidase inhibitors improves myocardial ischemic damage by reducing the level of neuraminidase. The present invention further provides a pharmaceutical preparation comprising neuraminidase inhibitor(s) and pharmaceutically acceptable carrier(s), the pharmaceutical preparation can be used for reducing the level of neuraminidase, thus improving myocardial ischemic damage.
机译:本发明公开了神经氨酸酶及其抑制剂在心肌缺血和心肌梗死中的应用,提供了神经氨酸酶和心肌缺血损伤之间的相关性,以证明可通过抑制神经氨酸酶的活性来减轻心肌缺血性损伤,并证明神经氨酸酶可以被抑制。用作筛选预防,减轻和/或治疗心肌缺血性损伤药物的靶标。本发明还证明了神经氨酸酶抑制剂对心肌缺血损伤的缓解作用。神经氨酸酶抑制剂通过降低神经氨酸酶的水平来改善心肌缺血性损害。本发明进一步提供了包含神经氨酸酶抑制剂和药学上可接受的载体的药物制剂,该药物制剂可用于降低神经氨酸酶的水平,从而改善心肌缺血性损伤。

著录项

  • 公开/公告号US2019054055A1

    专利类型

  • 公开/公告日2019-02-21

    原文格式PDF

  • 申请/专利权人 CHINA PHARMACEUTICAL UNIVERSITY;

    申请/专利号US201616081436

  • 申请日2016-03-29

  • 分类号A61K31/215;A61K31/351;A61K38/47;A61K31/4375;A61P9/10;

  • 国家 US

  • 入库时间 2022-08-21 12:07:17

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号